Comparison of the efficacy of tyrosine-kinase inhibitor therapy versus chemotherapy as second-line treatment in elderly non-small cell lung cancer patients without epidermal growth factor receptor mutationsComparison of the efficacy of tyrosine-kinase inhibitor therapy versus chemotherapy as second-line treatment in elderly non-small cell lung cancer patients without epidermal growth factor receptor mutations
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.